GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 104 days ( -3.32 % )
Last Price $199.92 0 %
High/ Low $199.92 - $199.92 0%
Chg 7 Days N/A $199.92 $199.92
Chg 30 Days N/A $199.92 $199.92
Chg 12 mos 249.14 % $57.26 $199.92
Trend - 3 mos N/A Width: 0 %
Trend - 12 mos 266.55 % Width: 43.24 %
Pred. range - 3 mos N/A - N/A -100.00 % - -100.00 %
Pred. range - 12 mos $674.88 - $966.71 237.58 % - 383.55 %
Short MA avg 3 mos Sell 0000-00-00 - N/A days
Long MA avg 3 mos Sell 0000-00-00 - N/A days
Short/Long MA avg 3 mos Sell 0000-00-00 - N/A days
Short MA avg 12 mos Buy 2023-05-22 - 80 days
Long MA avg 12 mos Buy 2022-12-06 - 194 days
Short/Long MA avg 12 mos Buy 2022-12-07 - 193 days
Pivot Short Sell 2023-09-13 - 2 days
Bollinger Sell 0000-00-00 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Prometheus Biosciences Inc

Prometheus Biosciences Prometheus Biosciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics and companion diagnostics products for the treatment of inflammatory bowel diseases (IBD). Its lead product includes PRA023, a humanized IgG1 monoclonal antibody (mAb), which is in Phase IIa clinical trial for the treatment of ulcerative colitis and Crohn's disease, as well as systemic sclerosis-associated ... RXDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT